2293.HK
Bamboos Health Care Holdings Limited
HKSEHKDEQUITY
Industrials
DELAYED
Last price
0.36
■ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
0.36
Day high
0.36
Day low
0.36
Volume
16.00K
Market cap
$144.17M
P/E (TTM)
9.00
52W range
0.36 – 0.58
Trailing performance
Returnvs SPY
1W
-2.70%
-1.5%
1M
-1.37%
-4.7%
3M
-5.26%
-7.7%
6M
-26.53%
-38.4%
YTD
-26.53%
-38.5%
1Y
-37.93%
-58.1%
3Y
-52.00%
-127.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 2293.HK open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
302.86M
Total on file
Fundamentals
Market cap$144.17M
Enterprise value$163.10M
Revenue (TTM)$70.43M
Gross profit$35.60M
EBITDA$19.57M
Net income$16.72M
EPS (TTM)$0.04
Free cash flow$22.35M
Total cash$42.19M
Total debt$60.40M
Book value / share$0.63
Shares outstanding400.47M
Float99.60M
Short % of float—
Dividend yield11.11%
Beta (5Y)-0.03
Valuation & profitability ratios
Trailing P/E9.00
Forward P/E—
PEG ratio—
Price / sales—
Price / book0.57
EV / revenue2.32
EV / EBITDA8.33
Gross margin50.54%
Operating margin21.45%
Profit margin23.74%
Return on equity7.01%
Return on assets3.36%
Debt / equity23.77
Current ratio0.81
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | — | $94.79M | $126.56M | $140.29M | — |
| Operating revenue | — | $94.79M | $126.56M | $140.29M | — |
| Cost of revenue | — | $10.07M | $48.74M | $8.67M | — |
| Gross profit | — | $84.72M | $77.82M | $131.63M | — |
| Selling, general & admin | — | $4.39M | $5.34M | $6.22M | — |
| Total operating expense | — | $43.59M | $24.71M | $59.07M | — |
| Operating income | — | $41.12M | $53.11M | $72.56M | — |
| Net interest income | — | -$2.08M | -$1.61M | -$1.14M | — |
| Pre-tax income | — | $39.23M | $58.67M | $72.44M | — |
| Tax provision | — | $8.31M | $11.76M | $13.82M | — |
| Net income | — | $30.92M | $46.92M | $58.62M | — |
| Net income to common | — | $30.92M | $46.92M | $58.62M | — |
| Basic EPS | 0.04 | 0.08 | 0.12 | 0.15 | -43.3% |
| Diluted EPS | 0.04 | 0.08 | 0.12 | 0.15 | -43.5% |
| EBIT | — | $42.03M | $60.62M | $73.21M | — |
| EBITDA | — | $52.17M | $70.61M | $80.90M | — |
| Basic shares | 400.27M | 400.00M | 400.00M | 400.00M | +0.1% |
| Diluted shares | 400.96M | 400.14M | 400.00M | 400.00M | +0.2% |
| Line item | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $81.15M | $93.27M | $86.27M | -13.0% |
| Cash & short-term investments | $81.15M | $93.27M | $86.27M | -13.0% |
| Accounts receivable | $38.91M | $46.27M | $44.76M | -15.9% |
| Inventory | $1.19M | $1.94M | $3.18M | -39.0% |
| Total current assets | $127.99M | $153.01M | $142.50M | -16.3% |
| Property, plant & equipment | $168.43M | $176.90M | $182.50M | -4.8% |
| Total assets | $318.06M | $346.83M | $351.35M | -8.3% |
| Total current liabilities | $99.70M | $123.86M | $140.69M | -19.5% |
| Current debt | $63.12M | $65.53M | $68.23M | -3.7% |
| Total debt | $63.73M | $68.24M | $68.96M | -6.6% |
| Total liabilities | $99.74M | $124.51M | $140.75M | -19.9% |
| Retained earnings | — | $176.61M | $165.35M | — |
| Shareholder equity | $218.33M | $222.32M | $210.60M | -1.8% |
| Working capital | $28.29M | $29.14M | $1.81M | -2.9% |
| Net tangible assets | $218.33M | $222.32M | $210.60M | -1.8% |
| Shares issued | 402.46M | 400.00M | 400.00M | +0.6% |
| Line item | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|
| Net income | $39.23M | $58.67M | $72.44M | -33.1% |
| Depreciation & amortisation | $10.13M | $9.99M | $7.69M | +1.4% |
| Change in working capital | -$3.52M | -$8.39M | $38.21M | +58.0% |
| Operating cash flow | $37.41M | $41.94M | $116.11M | -10.8% |
| Capital expenditure | -$1.66M | -$261.00K | -$186.37M | -536.8% |
| Investing cash flow | -$7.09M | $6.92M | -$111.63M | -202.5% |
| Dividends paid | -$35.12M | -$35.00M | -$40.00M | -0.4% |
| Financing cash flow | -$42.44M | -$41.80M | $25.15M | -1.5% |
| Free cash flow | $35.75M | $41.67M | -$70.26M | -14.2% |
| End cash position | $81.15M | $93.27M | $86.27M | -13.0% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
| Line item | 2025-12-31 | 2024-12-31 | YoY |
|---|---|---|---|
| Cash & equivalents | $39.20M | $79.87M | -50.9% |
| Cash & short-term investments | $39.20M | $79.87M | -50.9% |
| Accounts receivable | $20.57M | $31.81M | -35.3% |
| Inventory | $734.00K | $2.41M | -69.5% |
| Total current assets | $65.16M | $117.25M | -44.4% |
| Property, plant & equipment | $158.23M | $165.15M | -4.2% |
| Total assets | $335.25M | $313.70M | +6.9% |
| Total current liabilities | $80.63M | $90.70M | -11.1% |
| Current debt | $59.53M | $62.02M | -4.0% |
| Total debt | $60.40M | $62.18M | -2.9% |
| Total liabilities | $81.20M | $90.97M | -10.7% |
| Retained earnings | — | $172.47M | — |
| Shareholder equity | $254.05M | $222.73M | +14.1% |
| Working capital | -$15.47M | $26.55M | -158.3% |
| Net tangible assets | $254.05M | $222.73M | +14.1% |
| Shares issued | 402.46M | 402.46M | 0.0% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders75.25%
Held by institutions0.00%
Institutions holding0
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
0.37
-1.91% from price
SMA 20
0.37
-1.71% from price
SMA 50
0.39
-6.49% from price
SMA 100
0.39
-7.93% from price
SMA 200
0.45
-19.36% from price
EMA 12
0.37
-1.75% from price
EMA 26
0.37
-3.10% from price
EMA 50
0.38
-5.35% from price
RSI (14)
40.2
Neutral
MACD (12,26,9)
-0.01
Hist 0.00
ATR (14)
0.01
1.98% of price
Realised vol 30D
37.0%
Annualised
Bollinger upper
0.38
20, 2σ
Bollinger lower
0.35
20, 2σ
50 / 200 cross
Death
0.39 vs 0.45
Trend bias
Below 200
-19.36%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.38
Less volatile than market
Correlation to SPY
0.10
Largely independent
Realised vol 30D
37.0%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-39.0%
Peak to trough
Max drawdown 5Y
-73.3%
Peak to trough
ATR 14
0.01
1.98% of price
Beta (reported)
-0.03
5Y monthly, from filing
Dividends & splits
Forward rate$0.04 / yr
Forward yield11.11%
5-year avg yield8.74%
Payout ratio95.92%
Ex-dividend dateDec 3, 2025
Next pay date—
Last split—
Split date—
Headlines
Micron's Big AI Test Is Coming This Week
GuruFocus.com · 4m ago
Alibaba Slides as $10.2 Billion AI Sale Dilutes Investors
GuruFocus.com · 4m ago
Media Advisory: Infrastructure Announcement in Scarborough
CNW Group · 4m ago
Jersey Mike's Subs Same-Store Sales Growth More Durable Than Peers, RBC Says
MT Newswires · 5m ago
HearingLife Introduces Oticon Reveal, the World's First Dual AI-Powered Hearing Aid
PR Newswire · 5m ago
France readies high school phone ban for next month
AFP · 6m ago
Announcement on the registration of share capital increase in Commercial Register
GlobeNewswire · 7m ago
DeepCura Unveils the Electronic Health Workforce (EHW) -- the Step Beyond the EHR
PR Newswire · 8m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.